Provided by Tiger Trade Technology Pte. Ltd.

CytomX Therapeutics

2.77
+0.07502.79%
Pre-market: 2.850.0850+3.07%08:01 EDT
Volume:6.87M
Turnover:19.00M
Market Cap:601.95M
PE:-6.08
High:2.87
Open:2.72
Low:2.67
Close:2.69
52wk High:8.21
52wk Low:1.93
Shares:217.70M
Float Shares:180.00M
Volume Ratio:1.72
T/O Rate:3.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4548
EPS(LYR):-0.1500
ROE:-37.75%
ROA:-19.58%
PB:1.99
PE(LYR):-18.43

Loading ...

Why Is CytomX Therapeutics Stock Falling On Wednesday?

Benzinga_recent_news
·
Mar 19

CytomX Therapeutics price target raised to $16 from $8 at Jefferies

TIPRANKS
·
Mar 18

CytomX Therapeutics Is Maintained at Buy by Guggenheim

Dow Jones
·
Mar 18

BUZZ-CytomX drops on $250 mln equity raise

Reuters
·
Mar 18

CytomX Therapeutics 45.9M share Secondary priced at $5.30

TIPRANKS
·
Mar 18

U.S. RESEARCH ROUNDUP-Factset, Lensar, Starbucks

Reuters
·
Mar 18

CytomX prices USD 250 million follow-on common stock and pre-funded warrant offering

Reuters
·
Mar 18

BRIEF-CytomX Therapeutics Prices Public Offering Of 45,990,567 Shares At $5.30 Per Share

Reuters
·
Mar 18

CytomX Therapeutics Inc - Prices Public Offering of 45,990,567 Shares at $5.30 per Share

THOMSON REUTERS
·
Mar 18

Stock Track | CytomX Therapeutics Plummets 5.19% Intraday Amid AI Regulatory Risk Disclosure

Stock Track
·
Mar 17

CytomX Therapeutics Inc : Guggenheim Raises Target Price to $15 From $10

THOMSON REUTERS
·
Mar 17

U.S. RESEARCH ROUNDUP- Biogen, Eli Lilly, Johnson & Johnson

Reuters
·
Mar 17

CytomX Therapeutics Confronts Rising AI Regulatory Risks and Cost Pressures

TIPRANKS
·
Mar 17

NASD Most Active Issues

Dow Jones
·
Mar 17

BRIEF-CytomX Therapeutics Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants

Reuters
·
Mar 17

BRIEF-CytomX Therapeutics Inc Files For Mixed Shelf Offering, Size Not Disclosed - SEC Filing

Reuters
·
Mar 17

CytomX Therapeutics launches USD 250 million follow-on stock offering

Reuters
·
Mar 17

CytomX Therapeutics files automatic mixed securities shelf

TIPRANKS
·
Mar 17

CytomX Therapeutics Inc - Commences $250 Mln Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Mar 17

CytomX Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Mar 17